Mereo BioPharma Group plc - Ordinary Shares (MREO)

CUSIP: 589492107

Q4 2021 13F Holders as of 31 Dec 2021

Holder snapshot 7 signals
Share change
+3,196,563
Put/Call ratio
276%
SEC-reported price per share
$1.60
Number of holders
67
Value change
-$12,163,504
Number of buys
34
Open additional details 1 more signal available
Number of sells
24
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
833,333,333

Security key

589492107

Report period

Q4 2021

Institutions

67

Top holders

10

Ownership snapshot

Top reported holders of MREO - Mereo BioPharma Group plc - Ordinary Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
0/15
Latest evidence
30 Sep 2021
13F Highest disclosed value: $41,781,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC has the largest disclosed position value at $41.78M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.
Disclosed position value Top 5
ORBIMED ADVISORS LLC $41.78M
Rubric Capital Management LP $27.35M
Point72 Asset Management, L.P. $24.14M
MONTANOVA CAPITAL, LLC $22.12M
Vivo Capital, LLC $16.72M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ORBIMED ADVISORS LLC
13F
Company
13F
—
denominator unverified
$41,781,000
17,264,764 shares
— 30 Sep 2021
Rubric Capital Management LP
13F
Company
13F
—
denominator unverified
$27,346,000
11,300,000 shares
— 30 Sep 2021
Point72 Asset Management, L.P.
13F
Company
13F
—
denominator unverified
$24,140,000
9,975,000 shares
— 30 Sep 2021
MONTANOVA CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$22,124,000
9,142,067 shares
— 30 Sep 2021
Vivo Capital, LLC
13F
Company
13F
—
denominator unverified
$16,715,000
6,907,189 shares
— 30 Sep 2021
Rock Springs Capital Management LP
13F
Company
13F
—
denominator unverified
$11,696,000
4,832,978 shares
— 30 Sep 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
67
Shares
90,856,815
Rows available
67
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
58
Q4 2021 holders
67
Holder diff
9
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 value Q4 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .